FARRAGUT PARTNERS LLP

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Pharmaceutical Association

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

General representation. Regulations and legislation relating to PBMs and drug pricing. Issues related to the 340B drug discount program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.